1. Sufentanil alleviates pre-eclampsia via silencing microRNA-24-3p to target 11β-Hydroxysteroid dehydrogenase type 2
- Author
-
Yang, Yue, Fu, Xu, JiaRong, Zhang, Miao, Zhao, and FangFang, Zhou
- Subjects
Sufentanil ,Bioengineering ,General Medicine ,Applied Microbiology and Biotechnology ,Rats ,MicroRNAs ,Pre-Eclampsia ,Pregnancy ,11-beta-Hydroxysteroid Dehydrogenase Type 2 ,Animals ,Humans ,Female ,Rats, Wistar ,Biotechnology - Abstract
Pre-eclampsia (PE) is a prevalent pregnancy disease characterized by insufficient trophoblast cell migration (HTR8/SVneo). Consequently, accelerating trophoblast cell proliferation might ameliorate PE. This study assessed the effects and molecular mechanisms of Sufentanil (SUF) on HTR8/SVneo cells proliferation. HTR8/SVneo cells and PE clinical samples were used. Peripheral blood was collected from PE patients' samples, and microRNA (miR)-24-3p and 11β-hydroxysteroid dehydrogenase type 2 (HSD11B2) was analyzed in the blood and cells. HTR8/SVneo cells were treated with varying SUF concentrations or transfected with miR-24-3p mimics/inhibitors, or HSD11B2 elevation vector. CCK-8, colony formation, transwell, and flow cytometry assays were then carried out. Association of miR-24 - 3p with HSD11B2 was investigated. PE animal model was constructed using Wistar rats to verify SUF's role on PE
- Published
- 2022
- Full Text
- View/download PDF